Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 2Lymphoma 2Leukemia, Myeloid, Acute 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hematologic Neoplasms 1Anemia, Sickle Cell 1Anemia, Aplastic 1

Interventions

Influenza Vaccines 2fludarabine 1Valganciclovir 1Therapeutics 1Surveys and Questionnaires 1Polymerase Chain Reaction 1Mesna 1Melphalan 1Immunoenzyme Techniques 1Honey 1Ganciclovir 1Foscarnet 1Flow Cytometry 1Drug Therapy 1Dapsone 1Cyclophosphamide 1Busulfan 1Bone Marrow Transplantation 1Antiviral Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Anemia, Aplastic × Bone Marrow Transplantation × Clear all
NCT07145411 2025-08-28

HOPE

Ossium Health, Inc.

Recruiting
10 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Sickle Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡